BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22938466)

  • 1. New model of in-situ xenograft lymphangiogenesis by a human colonic adenocarcinoma cell line in nude mice.
    Sun JJ; Jing W; Ni YY; Yuan XJ; Zhou HH; Fan YZ
    Asian Pac J Cancer Prev; 2012; 13(6):2823-8. PubMed ID: 22938466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
    Eroğlu A; Ersöz C; Karasoy D; Sak S
    Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of sorafenib on lymphangiogenesis in subcutaneously transplanted human cholangiocarcinoma in nude mice].
    Huang FK; Shi Z
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):808-12. PubMed ID: 21223684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
    Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
    Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intervention of rukangyin on the lymphangiogenesis in breast cancer metastasis nude spontaneous mouse model].
    Li XQ; Dang XG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1657-61. PubMed ID: 22384554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
    Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
    Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin α4 Induces Lymphangiogenesis and Metastasis via Upregulation of VEGF-C in Human Colon Cancer.
    Lv XH; Liu BQ; Li XM; Wang XC; Li XL; Ahmed N; Zhang YF
    Anat Rec (Hoboken); 2016 Jun; 299(6):741-7. PubMed ID: 26917449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer.
    Guo X; Chen Y; Xu Z; Xu Z; Qian Y; Yu X
    Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):217-22. PubMed ID: 19280060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer.
    Duff SE; Jeziorska M; Kumar S; Haboubi N; Sherlock D; O'Dwyer ST; Jayson GC
    Colorectal Dis; 2007 Nov; 9(9):793-800. PubMed ID: 17931169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
    Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer.
    Jach R; Dyduch G; Radon-Pokracka M; Przybylska P; Mika M; Dulinska-Litewka J; Zajac K; Huras H; Streb J; Stangel-Wojcikiewicz K; Dziadek O; Galarowicz B
    Neuro Endocrinol Lett; 2011; 32(4):530-9. PubMed ID: 21876509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of local hyperthermia on lymphangiogenic factors VEGF-C and -D in a nude mouse xenograft model of tongue squamous cell carcinoma.
    Liang X; Zhou H; Liu X; He Y; Tang Y; Zhu G; Zheng M; Yang J
    Oral Oncol; 2010 Feb; 46(2):111-5. PubMed ID: 20036606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
    He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
    J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.